Safety of 6000 intravitreal dexamethasone implants.

Bindu RajeshJavier Zarranz-VenturaAdrian T FungCatharina BuschNiroj Kumar SahooPatricio J Rodríguez-ValdésValentina SaraoSanjay Kumar MishraA Osman SaatciPatricia Udaondo MireteFrancesca AmorosoMichel Eid FarahPaolo LanzettaJ Fernando ArevaloLaurent KodjikianJay Chhablaninull null

Published in: The British journal of ophthalmology (2019)

This is the largest real-life study assessing the safety of intravitreal dexamethasone implant injections in various retinal conditions. Cataract progression and intraocular pressure rise are the most common side effects, but are often rather easily manageable.

Keyphrases

diabetic retinopathy
vascular endothelial growth factor
high dose
low dose
age related macular degeneration
optical coherence tomography
soft tissue
cataract surgery